Multiomics
infrastructure for
precision medicine
STaiMIC is building the multiomics research infrastructure layer for AI-driven precision medicine across the Mediterranean and Middle East.
Founded by Susan Nasif O-Adorisio, PhD
Four components.
One integrated system.
A coalition infrastructure designed to translate AI and multiomics science into clinical impact.
Multiomics research infrastructure anchored in Basilicata's EU Convergence Region — the operational core of STaiMIC.
One shared pipeline, activated through disease verticals as grants and partnerships land. Oncology, cardiovascular, rare disease.
Clinical AI models and validated reference datasets — the connective tissue between research and real-world clinical deployment.
Applied-AI education for practising clinicians, healthcare staff, and students. Building the human infrastructure for the future of medicine.
Building our
expert community
STaiMIC is assembling the human infrastructure to match the ambition of its science.
Scientific Advisory Board
Internationally recognised researchers and clinicians in multiomics, translational medicine, precision oncology, cardiovascular genomics, rare disease, federated data governance, and clinical AI.
Industry Advisory Group
Senior advisors from pharma, medtech, digital health, and health investment — connecting our pipeline to the right partners, markets, and regulatory pathways.
Project-Based Experts
Flexible roles in bioinformatics, biostatistics, data engineering, multiomics integration, federated systems, clinical study design, and EU regulatory affairs (MDR, IVDR, AI Act).
Ready to shape the future
of precision medicine?
Whether you're a researcher, clinician, investor, or industry partner — there's a place for you in the STaiMIC ecosystem.
Contact us →
Email us at admin@staimic.it
Subject line: SAB · IAG · Fractional · Partnership
This page, alongside the full STaiMIC website, will be published at the completion of legal entity formation, scheduled May/June 2026 in Basilicata.